Actavis Generics is a global pharmaceutical company focused on developing,
manufacturing ... In 1993, Actavis, then Watson, announced its initial public
offering (IPO) of shares of common stock. ......
Watson Pharmaceuticals, Inc. manufactures, markets and/or distributes more
than 643 drugs in the U.S..
Jan 24, 2013 ... PARSIPPANY, N.J., Jan. 24, 2013 /PRNewswire/ -- Watson Pharmaceuticals, Inc.
today announced that the company has adopted Actavis, Inc.
May 13, 2016 ... MERCK & CIE v. WATSON LABORATORIES INC. 3 considered by the parties
was a joint venture to market and distribute MTHF. J.A. 1287–90 ...
Dec 14, 2012 ... The FTC required Watson Pharmaceuticals, Inc. and Actavis Inc. to sell the rights
and assets to 18 drugs to Sandoz International GmbH and Par ...
The latest litigation news involving the company Watson Pharmaceuticals Inc. (
May 16, 2016 ... ... in Merck & Cie v. Watson Laboratories, Inc., ANDA litigation over claim 4 of
U.S. Patent No. 6441168, which reads: A crystalline calcium salt ...
Watson Pharmaceuticals, Inc. (NYSE-WPI) is a global specialty pharmaceutical
company with approximately $3 billion in revenues, a broad product line and ...
Oct 15, 2012 ... The Federal Trade Commission will require Watson Pharmaceuticals, Inc. and
Actavis Inc. to sell the rights and assets to 18 drugs to Sandoz ...
Jun 17, 2013 ... Watson Pharmaceuticals, Inc., a corporation; Par Pharmaceutical Companies, Inc
., a corporation; Paddock Laboratories, Inc., a corporation; ...